ArticleCurrent oncology (Toronto, Ont.)2023

Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma.

Alexander Villalobos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.